NO20045497L - Fremgangsmate for fremstilling av 5-(1,3-oksazol-2-yl)benzosyrederivater - Google Patents

Fremgangsmate for fremstilling av 5-(1,3-oksazol-2-yl)benzosyrederivater

Info

Publication number
NO20045497L
NO20045497L NO20045497A NO20045497A NO20045497L NO 20045497 L NO20045497 L NO 20045497L NO 20045497 A NO20045497 A NO 20045497A NO 20045497 A NO20045497 A NO 20045497A NO 20045497 L NO20045497 L NO 20045497L
Authority
NO
Norway
Prior art keywords
sub
oxazol
preparation
benzoic acid
acid derivatives
Prior art date
Application number
NO20045497A
Other languages
English (en)
Other versions
NO20045497D0 (no
Inventor
Michael R Reeder
Rick J Imbordino
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of NO20045497D0 publication Critical patent/NO20045497D0/no
Publication of NO20045497L publication Critical patent/NO20045497L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)

Abstract

Forbindelser med Formel III og en fremgangsmåte for å fremstille en forbindelse med Formel III er beskrevet hvor R1, R2, R3 og R6 er definert her, bruker et sinkklorid/eventuelt substituerer oksazol addukt og en forbindelse med Formel I. Videre beskrevet er fremgangsmåter for å bruke forbindelser med Formel III til å fremstille forbindelser som er nyttige i behandlingen av Alzheimer's sykdom og relaterte tilstander.
NO20045497A 2002-06-20 2004-12-16 Fremgangsmate for fremstilling av 5-(1,3-oksazol-2-yl)benzosyrederivater NO20045497L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39028502P 2002-06-20 2002-06-20
US45047803P 2003-02-27 2003-02-27
PCT/US2003/019585 WO2004000821A1 (en) 2002-06-20 2003-06-20 Process for preparing 5-(1, 3-oxazol-2-yl) benzoic acid derivatives

Publications (2)

Publication Number Publication Date
NO20045497D0 NO20045497D0 (no) 2004-12-16
NO20045497L true NO20045497L (no) 2005-03-07

Family

ID=30003150

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20045497A NO20045497L (no) 2002-06-20 2004-12-16 Fremgangsmate for fremstilling av 5-(1,3-oksazol-2-yl)benzosyrederivater

Country Status (18)

Country Link
US (2) US7115747B2 (no)
EP (1) EP1532123B1 (no)
JP (1) JP2005533811A (no)
CN (1) CN1324017C (no)
AT (1) ATE370131T1 (no)
AU (1) AU2003249344A1 (no)
BR (1) BR0312439A (no)
CA (1) CA2489988A1 (no)
CO (1) CO5670350A2 (no)
DE (1) DE60315664D1 (no)
EA (1) EA008389B1 (no)
HK (1) HK1081543A1 (no)
IL (1) IL165763A0 (no)
MX (1) MXPA04012630A (no)
NO (1) NO20045497L (no)
NZ (1) NZ537390A (no)
PL (1) PL374999A1 (no)
WO (1) WO2004000821A1 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7351738B2 (en) * 2002-11-27 2008-04-01 Elan Pharmaceuticals, Inc. Substituted ureas and carbamates
TW200738701A (en) 2005-07-26 2007-10-16 Du Pont Fungicidal carboxamides
US7745484B2 (en) 2005-11-21 2010-06-29 Amgen Inc. Beta-secretase modulators and methods of use
US7872009B2 (en) * 2005-11-21 2011-01-18 Amgen Inc. Beta-Secretase modulators and methods of use
US7838676B2 (en) * 2005-11-21 2010-11-23 Amgen Inc. Beta-secretase modulators and methods of use
EP1971598A1 (en) 2005-11-21 2008-09-24 Amgen Inc. Beta-secretase modulators and methods of use
US20080277393A1 (en) * 2007-05-07 2008-11-13 True Charles W Collapsible, stackable, semi-rigid universal cotainer for hazardous and non-hazardous goods
WO2008147544A1 (en) 2007-05-25 2008-12-04 Amgen Inc. Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
US8163909B2 (en) 2007-05-25 2012-04-24 Amgen Inc. Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
US7803809B2 (en) 2008-11-12 2010-09-28 Amgen Inc. Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of use
EA201100461A1 (ru) 2008-09-11 2011-10-31 Амген Инк. Спиро-трициклические соединения как модуляторы бета-секретазы и способы их использования
WO2011063233A1 (en) 2009-11-23 2011-05-26 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
WO2011063272A1 (en) 2009-11-23 2011-05-26 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
CA2788363A1 (en) 2010-01-19 2011-07-28 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
AU2011227511B2 (en) 2010-03-15 2014-02-20 Amgen Inc. Spiro-tetracyclic ring compounds as Beta - secretase modulators
EP2547686B1 (en) 2010-03-15 2014-01-22 Amgen Inc. Amino-dihydrooxazine and amino-dihydrothiazine spiro compounds as beta-secretase modulators and their medical use
WO2012109165A1 (en) 2011-02-07 2012-08-16 Amgen Inc. 5-amino-oxazepine and 5-amino-thiazepane compounds as beta-secretase antagonists and methods of use
WO2013044092A1 (en) 2011-09-21 2013-03-28 Amgen Inc. Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
WO2014078314A1 (en) 2012-11-15 2014-05-22 Amgen Inc. Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
US11272751B2 (en) 2016-03-01 2022-03-15 Nicholas Popejoy Protective headgear, impact diffusing systems and methods
US9462841B1 (en) 2016-03-01 2016-10-11 William Popejoy Protective headgear and shoulder pad apparatus and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020276A1 (es) * 2000-06-30 2002-04-06 Elan Pharm Inc COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
MXPA04003245A (es) * 2001-10-04 2004-08-11 Elan Pharm Inc Hidroxipropilaminas.
US7176242B2 (en) * 2001-11-08 2007-02-13 Elan Pharmaceuticals, Inc. N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
GB0325830D0 (en) * 2003-11-05 2003-12-10 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
IL165763A0 (en) 2006-01-15
US7115747B2 (en) 2006-10-03
CO5670350A2 (es) 2006-08-31
US20070105921A1 (en) 2007-05-10
NZ537390A (en) 2006-07-28
DE60315664D1 (de) 2007-09-27
US20040063965A1 (en) 2004-04-01
NO20045497D0 (no) 2004-12-16
ATE370131T1 (de) 2007-09-15
JP2005533811A (ja) 2005-11-10
EP1532123A1 (en) 2005-05-25
MXPA04012630A (es) 2005-09-30
BR0312439A (pt) 2005-05-10
EP1532123B1 (en) 2007-08-15
EA200401510A1 (ru) 2005-06-30
CN1324017C (zh) 2007-07-04
WO2004000821A1 (en) 2003-12-31
HK1081543A1 (en) 2006-05-19
EA008389B1 (ru) 2007-04-27
CN1662510A (zh) 2005-08-31
CA2489988A1 (en) 2003-12-31
AU2003249344A1 (en) 2004-01-06
PL374999A1 (en) 2005-11-14

Similar Documents

Publication Publication Date Title
HK1081543A1 (en) Process for preparing 5-(1,3-oxazol-2-yl) benzoic acid derivatives
MY142807A (en) Benzimidazole derivative and use thereof.
EA200500006A1 (ru) Лекарственное средство для лечения нейродегенеративных заболеваний
WO2004094384A3 (en) (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer’s disease
EA200101194A1 (ru) Производные 4,5,6,7-тетрагидроиндазола в качестве противоопухолевых средств
MY142768A (en) Gfat inhibitors
ATE354562T1 (de) Cyclohexylsulfon-derivate als gamma-secretase- inhibitoren
TW200510405A (en) Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors
CY1116885T1 (el) Υποκατεστημενα παραγωγα κυκλοεξυλομεθυλιου
EA200501820A1 (ru) Терапевтические средства для лечения боли
EA200401114A3 (ru) Замещённые гидроксиэтиламины
DE50304030D1 (de) Verfahren zur Herstellung von 5-Nitrobenzofuranen
GEP20074045B (en) (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
DE602004011255D1 (de) Phosphinsäurederivate, inhibitoren von beta-sekretase zur behandlung von alzheimer-krankheit
NO20054418L (no) Substituert benzoylureidopyridylpiperidin- og -pyrrolidinkarboksylsyrederivater, deres fremstilling og anvendelse
TW200637856A (en) Process for producing thiazolidinedion compound and intermediate thereof
DE602004019778D1 (de) Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen
RU2004126861A (ru) Производные пиридинамидов в качестве ингибиторов моноаминоксидазы (мао-в)
NO20073213L (no) Fremgangsmate for fremstilling av tiofenglykosidderivater
NO20070972L (no) Benzyloksyderivater som MAOB-inhibitorer
JP2007507467A5 (no)
GB0003257D0 (en) Heterocyclic compounds and their therapeutic use
NO330965B1 (no) Fremgangsmate for fremstilling av substituerte imidazolderivater, mellomprodukter anvendt i fremgangsmaten samt fremgangsmate for fremstilling av mellomprodukt
NO20033049D0 (no) Fremgangsmåte for fremstilling av (+/-) trans-4-p-fluorfenyl- 3-hydroksymetyl-1
WO2004032854A3 (en) Pharmaceutical compositions for treatment of parkinson's disease

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application